Andrew C. Weiss
Investor Relations Contact at IDORSIA LTD
Network origin in Andrew C. Weiss first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
21
| Public Company | Pharmaceuticals: Major | 21 |
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Julius Baer Holding AG
4
| Extinct | Major Banks | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Andrew C. Weiss via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| CELGENE | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | President President Director of Finance/CFO | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| GAM HOLDING AG | Investment Managers | Corporate Officer/Principal Chairman | |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Epirium Bio, Inc. develops therapeutics for orphan and rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems. The company was founded in 2008 by Alan Stewart Maisel, Sundeep Dugar, and Francisco Villarreal and is headquartered in Los Altos Hills, CA. | Pharmaceuticals: Major | Director/Board Member | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | General Counsel Director of Finance/CFO | |
| GSK PLC | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Bank Julius Bär & Co. AG
 Bank Julius Bär & Co. AG Investment ManagersFinance Bank Julius Bär & Co. AG (BJB) is the private banking subsidiary of Julius Bär Gruppe AG (SWX: BAER) in Switzerland. Headquartered in Zurich, BJB was founded in 1890 and provides personal wealth management advice to private clients and family offices. | Investment Managers | President Chief Executive Officer | |
| Stanford University | College/University | Masters Business Admin Masters Business Admin | |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director of Finance/CFO | |
Pierre Fabre Médicament SAS
 Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Other | Chief Operating Officer | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Actelion Pharmaceuticals UK Ltd.
 Actelion Pharmaceuticals UK Ltd. Medical DistributorsDistribution Services Actelion Pharmaceuticals UK Ltd. discovers, develops, and markets drugs. Its products are Tracleer for the treatment of pulmonary arterial hypertension and Zavesca, which is used to treat Type 1 Gaucher disease. The company is headquartered in London, UK. | Medical Distributors | Director/Board Member Chief Executive Officer | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Chairman Director/Board Member | |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Pharmaceuticals: Major | President | |
| University of Zurich | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of Bern | College/University | Undergraduate Degree Undergraduate Degree | |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| MOLECULAR PARTNERS AG | Biotechnology | Chairman General Counsel | |
Kein & Aber AG
 Kein & Aber AG Publishing: Books/MagazinesConsumer Services Kein & Aber AG engages in publishing books. It publishes books, pocketbooks, electronic books, digital versatile disc's, gift books, and pics and picks. The company was founded by Peter George Haag on June 26, 1992 and is headquartered in Zurich, Switzerland. | Publishing: Books/Magazines | Director/Board Member | |
The Association of the British Pharmaceutical Industry
 The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | President | |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer | |
| CARMAT | Medical Specialties | Chairman Director/Board Member | |
| PHARNEXT SCA | Biotechnology | Director/Board Member Chairman | |
| JULIUS BÄR GRUPPE AG | Financial Conglomerates | Director/Board Member Chief Executive Officer | |
GlaxoSmithKline Pharma A/S
 GlaxoSmithKline Pharma A/S Medical DistributorsDistribution Services GlaxoSmithKline Pharma A/S operates as a science-led global healthcare company. It develops and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company was founded on December 11, 1968 and is headquartered in Brondby, Denmark. | Medical Distributors | Corporate Officer/Principal | |
| The Danish Association of the Pharmaceutical Industry | Corporate Officer/Principal | ||
| Fisons Pharmaceuticals | Corporate Officer/Principal | ||
| Nancy-Université | College/University | Doctorate Degree | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
StartAngels Network
 StartAngels Network Packaged SoftwareTechnology Services StartAngels Network operates as a platform for business angel investors. Its angle investors invest directly in the start-up companies, coach them, and provide useful contacts. The company was founded by Peter H. Müller in 2000 and is headquartered in Zurich, Switzerland. | Packaged Software | Corporate Officer/Principal | |
Malcisbo AG
 Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Chairman | |
| Cornell Law School | College/University | Graduate Degree | |
| New York University School of Law | College/University | Graduate Degree | |
Celgene Switzerland SARL
 Celgene Switzerland SARL Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Switzerland SARL is a Swiss biopharmaceutical company. The private company is based in Boudry, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The private company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member | |
National Resilience, Inc.
 National Resilience, Inc. Miscellaneous Commercial ServicesCommercial Services National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | President | |
Idorsia Pharmaceuticals Japan Ltd.
 Idorsia Pharmaceuticals Japan Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Japan Ltd. is a private company based in Tokyo, Japan. The Japanese company's description focuses on a nationwide contest aimed at expressing gratitude to medical professionals and raising awareness about the role of medicine and healthcare in society. The contest is designed to encourage elementary school students to think about their future dreams, their own and their family's health, and a society where everyone can live a healthy life both physically and mentally. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Medyria AG
 Medyria AG BiotechnologyHealth Technology Medyria AG develops technologies for endovascular catheter navigation and sensing. Its products include trackcath, flowcath and OEM flow sensor. The firm's technology is a sensor-based system combined with a novel approach for processing flow data and tracking catheters. The targeted medical domains comprise vascular, valve, and heart procedures. The company's products increase accuracy reducing complications and risks, fostering the conversion from open surgery to minimally invasive approach. Medyria was founded by Mauro Massimo Sette in 2012 and is headquartered in Winterthur, Switzerland. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 20 |
| Switzerland | 16 |
| France | 9 |
| United Kingdom | 6 |
| Denmark | 3 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Finance | 4 |
| Distribution Services | 3 |
Operational
| Director/Board Member | 168 |
| Corporate Officer/Principal | 71 |
| Chairman | 55 |
| Independent Dir/Board Member | 39 |
| Chief Executive Officer | 32 |
Most connected contacts
| Insiders | |
|---|---|
| Jean-Pierre Garnier | 28 |
| Michel de Rosen | 28 |
| Felix R. Ehrat | 27 |
| Mathieu Simon | 22 |
| Hendrica Verhagen | 22 |
| Peter Kellogg | 21 |
| Viviane Monges | 21 |
| David Stout | 19 |
| Bernhard Hodler | 17 |
| Sophie Kornowski-Bonnet | 16 |
| Jörn Aldag | 15 |
| Sandy Mahatme | 13 |
| Otto Schwarz | 13 |
| Rolf P. Jetzer | 13 |
| Srishti Gupta | 11 |
- Stock Market
- Insiders
- Andrew C. Weiss
- Company connections
